These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2244666)

  • 1. Actinic keratoacanthoma. Speculations on the nature of the lesion and the role of cellular immunity in its evolution.
    Lawrence N; Reed RJ
    Am J Dermatopathol; 1990 Oct; 12(5):517-33. PubMed ID: 2244666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
    Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
    J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell and squamous cell carcinomas. Clinico-histological features.
    Annessi G; Baliva G
    Ann Ist Super Sanita; 1996; 32(1):29-36. PubMed ID: 8804183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Kossard S; Tan KB; Choy C
    Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues with keratoacanthoma, pseudoepitheliomatous hyperplasia and squamous cell carcinoma within tattoos: a clinical point of view.
    Kluger N
    J Cutan Pathol; 2010 Jul; 37(7):812-3. PubMed ID: 19614733
    [No Abstract]   [Full Text] [Related]  

  • 6. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
    Lee YS; Teh M
    Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
    Tan KB; Lee YS
    Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratoacanthoma: clinical and histopathologic features of regression.
    Ko CJ; McNiff JM; Bosenberg M; Choate KA
    J Am Acad Dermatol; 2012 Nov; 67(5):1008-12. PubMed ID: 22521202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratoacanthoma occurring within the red dye of a tattoo.
    Kluger N; Minier-Thoumin C; Plantier F
    J Cutan Pathol; 2008 May; 35(5):504-7. PubMed ID: 17976209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
    Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
    J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible key role of granzyme B in keratoacanthoma regression.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I
    Med Hypotheses; 2006; 66(6):1129-32. PubMed ID: 16497444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidermoid carcinoma or keratoacanthoma?].
    Estruch R; Aguilera MT; Cardellach F; Palou J
    Med Clin (Barc); 1986 Oct; 87(11):477. PubMed ID: 3784650
    [No Abstract]   [Full Text] [Related]  

  • 15. Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.
    Arnault JP; Wechsler J; Escudier B; Spatz A; Tomasic G; Sibaud V; Aractingi S; Grange JD; Poirier-Colame V; Malka D; Soria JC; Mateus C; Robert C
    J Clin Oncol; 2009 Aug; 27(23):e59-61. PubMed ID: 19597016
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of UV induced keratoacanthoma-like lesions in HRA/Skh-1 mice and their comparison with keratoacanthomas in man.
    Canfield PJ; Greenoak GE; Reeve VE; Gallagher CH
    Pathology; 1985 Oct; 17(4):613-6. PubMed ID: 2419826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histogenesis and progression in ultraviolet light-induced tumors in hairless mice.
    Kligman LH; Kligman AM
    J Natl Cancer Inst; 1981 Dec; 67(6):1289-93. PubMed ID: 6947111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo-epitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma occurring within tattoos: diagnostic issues.
    Kluger N; Plantier F
    J Am Acad Dermatol; 2007 Nov; 57(5):901-2. PubMed ID: 17939943
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic detection of markers of keratinocyte differentiation. Its use in neoplastic and preneoplastic lesions of skin.
    Kvedar JC; Fewkes J; Baden HP
    Arch Pathol Lab Med; 1986 Mar; 110(3):183-8. PubMed ID: 2418804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.